United States - English - NLM (National Library of Medicine)

medinatura new mexico, inc - active ingredients purpose, *aconitum napellus 1x 0.08%, *arnica montana 1x 3.3%, *arnica montana 3x 2.51%, *arnica montana10x 0.12%, *wild harvest baptisia tinctoria 4x 0.75%, *belladonna 2x 0.75%, *bellis perennis 2x 0.75%, *organic calendula officinalis 1x 2.51%, *organic chamomilla 2x 0.91%, *organic echinacea 1x 0.75%, *hamamelis virginiana 2x 2.26%, *hypericum perforatum 6x 0.12%, *organic millefolium 2x 2.71%, *ruta graveolens 4x 3%, *symphytum officinale 4x 0.15%, *natural. t-relief extra strength c - pain relief for muscles and joints provides temporary relief from pain due to minor ijury, joint problems, overexertion

United States - English - NLM (National Library of Medicine)

medinatura inc - active ingredients purpose, *aconitum napellus 1x 0.08%................reduces joint and back pain, *arnica montana 1x 3.3%........reduces arthritis and back pain, *arnica montana 3x 2.51%..........reduces arthritis and back pain, *arnica montana10x 0.12%........reduces arthritis and back pain, *wild harvest baptisia tinctoria 4x 0.75% ..................relieves joint and muscle soreness, *belladonna 2x 0.75%...........................reduces back pain, *bellis perennis 2x 0.75%......................relieve - for the temporary relief of minor: joint pain • back pain • muscular pain • nerve pain, arthritis pain for the temporary relief of minor: joint pain • back pain • muscular pain • nerve pain, arthritis pain

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

tanzania engineering and manufacturing design organization (temdo), tanzania - delivery bed complete with leg holders -

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - theophylline 250mg;  ; theophylline 250mg - modified release tablet - 250 mg - active: theophylline 250mg   excipient: cellacefate lactose monohydrate magnesium stearate active: theophylline 250mg excipient: guar gum magnesium stearate - nuelin-sr tablets are indicated for the relief and prophylaxis of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.

New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - methylnaltrexone bromide 12mg (12mg in 0.6ml) - solution for injection - 12 mg/0.6ml - active: methylnaltrexone bromide 12mg (12mg in 0.6ml) excipient: glycine hydrochloric acid sodium calcium edetate sodium chloride sodium hydroxide water for injection - relistor is indicated for the treatment of opioid-induced constipation in patients with advanced illness who are receiving palliative care when response to laxative therapy has not been sufficient.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - estradiol hemihydrate, quantity: 1.033 mg (equivalent: estradiol, qty 1 mg); drospirenone, quantity: 2 mg - tablet, film coated - excipient ingredients: povidone; hypromellose; magnesium stearate; lactose monohydrate; purified talc; macrogol 6000; titanium dioxide; pregelatinised maize starch; maize starch; iron oxide red - hormone replacement therapy (hrt) for use in the short-term treatment in postmenopausal women with an intact uterus of the climacteric syndrome caused by deficient endogenous oestrogen production due to natural menopause, hypogonadism, castration or primary ovarian failure.

United States - English - NLM (National Library of Medicine)

daiichi sankyo, inc. - cevimeline hydrochloride (unii: p81q6v85np) (cevimeline - unii:k9v0cdq56e) - cevimeline is indicated for the treatment of symptoms of dry mouth in patients with sjögren’s syndrome. cevimeline is contraindicated in patients with uncontrolled asthma, known hypersensitivity to cevimeline, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle-closure) glaucoma.

United States - English - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - cevimeline hydrochloride (unii: p81q6v85np) (cevimeline - unii:k9v0cdq56e) - cevimeline is indicated for the treatment of symptoms of dry mouth in patients with sjögren’s syndrome. cevimeline is contraindicated in patients with uncontrolled asthma, known hypersensitivity to cevimeline, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle-closure) glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - a single-use medicine administration kit containing a vial of medication, vial of sterile diluent, syringe and associated needles used to administer a single dose of the medication.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

eli lilly export sa, switzerland - insulin - solution for injection - 100 iu/ml